Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 131

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 1
Chunk 131
---
 as defined under SEC Regulation Item 404, to the extent required
by SEC regulations.

Separation Agreement with Former CEO

In connection with Charles
J. Fisher, Jr. M.D.’s resignation as the Company’s Chief Executive Officer, effective November 2023, (the “Fisher Separation
Date”), in accordance with the terms of his Executive Employment Agreement with the Company, dated as of October 30, 2020 (the “Fisher
Employment Agreement”), and pursuant to Dr. Fisher’s Separation Agreement with the Company, effective as of November 27, 2023
(the “Fisher Separation Agreement”), the Company will provide Dr. Fisher with (1) cash severance equivalent to twelve months
of Dr. Fisher’s base salary in effect as of the Separation Date, subject to standard payroll deductions and withholdings, payable
over the Company’s regular payroll schedule over the twelve months following the Separation Date; (2) the accelerated vesting on
fifty percent (50%) of the outstanding and unvested equity awards held by Dr. Fisher that were subject to time-based vesting as of the
Fisher Separation Date, which were deemed fully vested and exercisable as of the Fisher Separation Date; and (3) reimbursement of COBRA
healthcare premium costs for the same level of coverage Dr. Fisher had during his employment with the Company, until the earliest of (i)
twelve months from November 27, 2023, (ii) the date Dr. Fisher becomes eligible for substantially equivalent healthcare coverage through
another source, or (iii) the expiration of Dr. Fisher’s eligibility for the continuation coverage. Further, and pursuant to the
Separation Agreement, Dr. Fisher provided the Company with a general release of all claims, effective November 27, 2023.

Separation Agreement with Former COO

Guy Cipriani’s termination
as the Company’s Chief Operating Officer effective October 2024 (the “Cipriani Separation Date”), in accordance with
the terms of his Executive Employment Agreement with the Company, dated as of October 30, 2020 (the “Cipriani Employment Agreement”),
and pursuant to Mr. Cipriani’s Separation Agreement with the Company, effective as of October 3, 2024 (the “Cipriani Separation
Agreement”), the Company will provide Mr. Cipriani with (1) cash severance equivalent